Market Overview

UPDATE: Deutsche Bank Reiterates Buy Rating, Raises PT on XenoPort

Related XNPT
XenoPort's XP23829 in Phase II Study - Analyst Blog
Xenoport, Inc. (XNPT) Soars: Stock Up 5.9% - Tale of the Tape

In a report published Friday, Deutsche Bank reiterated its Buy rating on XenoPort (NASDAQ: XNPT), and raised its price target from $10.00 to $12.00.

Deutsche Bank noted, “Maintain Buy following positive initial clinical data for XP'829. XenoPort's transporter technology platform potentially offers a deep pipeline of opportunities, including XP'986 for spasticity, XP'829 (“BG12” like compound), and recently launched Regnite (Astellas) in Japan, etc. Hence, we continue to view XenoPort as an attractive investment opportunity despite the ongoing dispute over Horizant with GSK.”

XenoPort closed on Thursday at $11.15.

Posted-In: Deutsche BankAnalyst Color Price Target Analyst Ratings

 

Related Articles (XNPT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters